Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Gastroenterology|March 7, 2001
Molecular anatomy and pathophysiologic implications of drug resistance in hepatitis B virus infectionE Doo, T J LiangThe American Journal of Pathology|April 1, 1987
Absence of tubular myelin in lungs of infants dying with hyaline membrane diseaseD E deMello, E Y Chi, E Doo, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 1, 1991
Quantification of hepatobiliary function as an integral part of imaging with technetium-99m-mebrofenin in health and diseaseE Doo, G T Krishnamurthy, M J Eklem, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 16, 2008
Improving long-term outcomes after liver transplantation in childrenJ C Bucuvalas, E Alonso, J C Magee, et al.Journal of Virology|August 10, 1999
Hepatitis B virus X protein is both a substrate and a potential inhibitor of the proteasome complexZ Hu, Z Zhang, E Doo, et al.Gastroenterology|November 1, 1989
Inhibition of duck hepatitis B virus replication by 2',3'-dideoxycytidine. A potent inhibitor of reverse transcriptaseC Kassianides, J H Hoofnagle, R H Miller, et al.Hepatology (Baltimore, Md.)|July 27, 1999
Lamivudine for chronic delta hepatitisD T Lau, E Doo, Y Park, et al.Journal of Viral Hepatitis|June 26, 2003
A rapid immunochromatographic assay for hepatitis B virus screeningD T-Y Lau, H Ma, S M Lemon, et al.Alimentary Pharmacology & Therapeutics|March 28, 2012
Randomised clinical trial: the benefit of combination therapy with adefovir and lamivudine for chronic hepatitis BM G Ghany, J J Feld, X Zhao, et al.Hepatology (Baltimore, Md.)|September 26, 2000
Long-term therapy of chronic hepatitis B with lamivudineD T Lau, M F Khokhar, E Doo, et al.Pageof 2